Kolon TissueGene Decides on 47.8 Billion KRW Paid-in Capital Increase
Kolon TissueGene announced on the 23rd that it has decided to conduct a paid-in capital increase worth 47.8 billion KRW to secure operating funds.
The company will issue 762,350 common shares at 62,460 KRW per share through a third-party allotment. The third-party allotment target is Kolon Co., Ltd., the largest shareholder.
Hot Picks Today
"Our Buldak Doesn't Taste Like That"... '11 Trillion Won in Counterfeits' That'll Leave Us Fuming
- Condoms Out of Stock... "Please Stop Having Kids": Country to Deliver Contraceptive Pills Door to Door
- Ceiling Collapses at Daegu Supermarket... Fire Authorities: "Rescue Operations Underway"
- "Busan Is in Big Trouble"... 'This Insect,' Capable of Producing 350 Nymphs From One Female, Confirmed to Have Established Itself
- "Should I Raid Mom's Bathroom First?"... Millennials & Gen Z Go Wild for This 10,000-Won Bath Essential
Regarding the selection process, the company stated, "The allocation was made considering the investor's intention and payment capability to achieve management objectives and raise funds."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
